Lucid Diagnostics Receives Nasdaq Notice Over Minimum Bid Price
The company said its stock closed below Nasdaq’s $1.00 minimum bid price for 30 consecutive business days through October 9, 2026. It has until April 12, 2027, to regain compliance.
The company said its stock closed below Nasdaq’s $1.00 minimum bid price for 30 consecutive business days through October 9, 2026. It has until April 12, 2027, to regain compliance.